Myfembree as BC? ASRM Data
Back in 2021, we discussed the FDA approval of a combination GNRH antagonist (relagolix) with estradiol and norethindrone. This was originally approved to treat uterine fibroid related heavy menstrual bleeding. It is also now approved for endometriosis care. In theory, this should also be an effective contraceptive agent. However, the FDA label strictly cautions against its use for birth control. In this episode, we will discuss data from the recent ASRM 2026 annual conference that looked at this medication's ability to possibly function as hormonal contraception. But there is a catch. Listen in for details.
1. https://www.medscape.com/viewarticle/fibroid-drug-relugolix-may-act-contraceptive-2026a10015db
2. Myfembreehcp.com
You May Also Like

Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio

Bigfoot Eyewitness Radio
Vic Cundiff

Created to Reign
Cornwall Alliance for the Stewardship of Creation

Universe Today Podcast
Fraser Cain

Oncology Today with Dr Neil Love
Dr. Neil Love

The Dissenter
Ricardo Lopes

This Week in Cardiology
Medscape

Accès au Marché Mondial des Dispositifs Médicaux
Pure Global

Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra

Глобальный доступ на рынок медицинских изделий
Pure Global
Community discussion